Posts tagged as

Desmond Schatz

UFDI investigators cited in two new type 1 diabetes studies

Desmond Schatz, M.D. and Bimota Nambam, Ph.D. recently released new publications. Both investigators co-authored Immune Intervention in Type 1 Diabetes, which reviews recently published immune interventional and mechanistic studies in T1D subjects. The highlighted publications consist of primary (before the development of islet autoantibodies) and secondary prevention studies…

Mobilization without immune depletion fails to restore immunological tolerance or preserve beta cell function in recent onset type 1 diabetes

UFDI investigators and collaborators found that granulocyte colony stimulating factor monotherapy did not affect C-peptide production, HbA1c, or insulin dose.This study supports the continued exploration of G-CSF and other mobilizing agents in subjects with T1D, but only when combined with immunodepleting agents where synergistic mechanisms of action have previously demonstrated…

Screening for T1D risk to reduce DKA is not economically viable

Several studies have documented reduced incidence of diabetic ketoacidosis (DKA) in new-onset T1D when high-risk children are identified at an early age. As a result, researchers have questioned whether T1D screening for the purpose of preventing DKA is a feasible option. UF researchers worked with Abt Associates to perform a…